156 related articles for article (PubMed ID: 1347312)
21. Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction.
Xing Z; Zganiacz A; Santosuosso M
J Leukoc Biol; 2000 Dec; 68(6):897-902. PubMed ID: 11129658
[TBL] [Abstract][Full Text] [Related]
22. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
23. IL-2. A cofactor for induction of activated macrophage resistance to infection.
Belosevic M; Finbloom DS; Meltzer MS; Nacy CA
J Immunol; 1990 Aug; 145(3):831-9. PubMed ID: 2115543
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of interferon-gamma in experimental visceral leishmaniasis in nude mice.
Murray HW; Hariprashad J; Aguero B; Arakawa T; Yeganegi H
J Infect Dis; 1995 May; 171(5):1309-16. PubMed ID: 7751708
[TBL] [Abstract][Full Text] [Related]
25. Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-alpha production by macrophages is induced by the synergistic action of interferon (IFN)-gamma and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN-gamma and IL 4.
Stenger S; Solbach W; Röllinghoff M; Bogdan C
Eur J Immunol; 1991 Jul; 21(7):1669-75. PubMed ID: 1905642
[TBL] [Abstract][Full Text] [Related]
26. [Importance of the different T lymphocytes subsets in immunity of mice against an intracellular protozoan parasite: Leishmania major].
Louis JA
Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):812-6. PubMed ID: 7906028
[TBL] [Abstract][Full Text] [Related]
27. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.
Titus RG; Kelso A; Louis JA
Clin Exp Immunol; 1984 Jan; 55(1):157-65. PubMed ID: 6198115
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity.
Ho JL; He SH; Rios MJ; Wick EA
J Infect Dis; 1992 Feb; 165(2):344-51. PubMed ID: 1309848
[TBL] [Abstract][Full Text] [Related]
29. Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes.
Mosser DM; Handman E
J Leukoc Biol; 1992 Oct; 52(4):369-76. PubMed ID: 1402387
[TBL] [Abstract][Full Text] [Related]
30. Cellular therapy by allogeneic macrophages against visceral leishmaniasis: role of TNF-α.
Manna PP; Hira SK; Basu A; Bandyopadhyay S
Cell Immunol; 2014 Jul; 290(1):152-63. PubMed ID: 24996013
[TBL] [Abstract][Full Text] [Related]
31. The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation.
Aversa G; Punnonen J; de Vries JE
J Exp Med; 1993 Jun; 177(6):1575-85. PubMed ID: 7684430
[TBL] [Abstract][Full Text] [Related]
32. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
33. [Effects of cytokine-activated macrophages on intracellular leishmania].
Xue C; Kaye P
Zhonghua Yi Xue Za Zhi; 1995 Jun; 75(6):338-40, 382. PubMed ID: 7553143
[TBL] [Abstract][Full Text] [Related]
34. Lymphokine-induced macrophage resistance to infection with Leishmania major.
Belosevic M; Davis CE; Meltzer MS; Nacy CA
Adv Exp Med Biol; 1988; 239():239-44. PubMed ID: 3202039
[TBL] [Abstract][Full Text] [Related]
35. Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo.
Theodos CM; Povinelli L; Molina R; Sherry B; Titus RG
Infect Immun; 1991 Aug; 59(8):2839-42. PubMed ID: 1906844
[TBL] [Abstract][Full Text] [Related]
36. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
37. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
Murray HW; Rubin BY; Carriero S; Acosta AM
J Immunol; 1984 Oct; 133(4):2250-4. PubMed ID: 6432909
[TBL] [Abstract][Full Text] [Related]
38. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
[TBL] [Abstract][Full Text] [Related]
39. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.
Liew FY; Millott S; Li Y; Lelchuk R; Chan WL; Ziltener H
Eur J Immunol; 1989 Jul; 19(7):1227-32. PubMed ID: 2503386
[TBL] [Abstract][Full Text] [Related]
40. Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi.
Rodriguez NE; Chang HK; Wilson ME
Infect Immun; 2004 Apr; 72(4):2111-22. PubMed ID: 15039333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
